[Gene delivery using adeno-associated (AAV) vectors]
- PMID: 9549360
[Gene delivery using adeno-associated (AAV) vectors]
Abstract
Gene transfer vectors based on the replication-defective adeno-associated virus (AAV) are emerging as promising vehicles for gene therapeutic approaches for the neurologic disease, cystic fibrosis and cancers. AAV vectors have been used to efficiently transduce genes into cells in vitro and in vivo. However, transduced recombinant AAV vectors are integrated into human chromosomes. Thus we have discussed that the review about the AAV vectors and transduction, and reported the results used AAV vectors for expression of ribozyme.
Similar articles
-
Current development of adeno-associated viral vectors.Drug News Perspect. 2005 Jun;18(5):311-6. doi: 10.1358/dnp.2005.18.5.917326. Drug News Perspect. 2005. PMID: 16193103 Review.
-
Adeno-associated virus vectors for gene therapy.Gene Ther. 1995 Aug;2(6):357-62. Gene Ther. 1995. PMID: 7584109 Review.
-
Preclinical study on gene therapy of cervical carcinoma using adeno-associated virus vectors.Cancer Gene Ther. 2000 May;7(5):766-77. doi: 10.1038/sj.cgt.7700178. Cancer Gene Ther. 2000. PMID: 10830724
-
[Gene transfer using adeno-associated virus (AAV) vectors].Nihon Rinsho. 1997 Aug;55(8):2156-9. Nihon Rinsho. 1997. PMID: 9284438 Review. Japanese.
-
Recombinant adeno-associated virus derived vectors (rAAV2) efficiently transduce ovarian and hepatocellular carcinoma cells--implications for cancer gene therapy.Acta Pol Pharm. 2009 Jan-Feb;66(1):93-9. Acta Pol Pharm. 2009. PMID: 19226976
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical